nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—Cough—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.0015	CcSEcCtD
Vigabatrin—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00149	0.00149	CcSEcCtD
Vigabatrin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.00148	CcSEcCtD
Vigabatrin—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.00148	CcSEcCtD
Vigabatrin—Cough—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00147	CcSEcCtD
Vigabatrin—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Vigabatrin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Vigabatrin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Vigabatrin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Vigabatrin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Vigabatrin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Vigabatrin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Vigabatrin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Vigabatrin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Vigabatrin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Vigabatrin—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Vigabatrin—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Vigabatrin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Vigabatrin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.00145	CcSEcCtD
Vigabatrin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.00145	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00145	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00145	CcSEcCtD
Vigabatrin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00144	0.00144	CcSEcCtD
Vigabatrin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.00144	CcSEcCtD
Vigabatrin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00143	CcSEcCtD
Vigabatrin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00143	CcSEcCtD
Vigabatrin—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00143	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00142	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00142	0.00142	CcSEcCtD
Vigabatrin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00141	CcSEcCtD
Vigabatrin—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00141	CcSEcCtD
Vigabatrin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.0014	CcSEcCtD
Vigabatrin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.0014	0.0014	CcSEcCtD
Vigabatrin—Infection—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00139	CcSEcCtD
Vigabatrin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00139	CcSEcCtD
Vigabatrin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00138	CcSEcCtD
Vigabatrin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00138	CcSEcCtD
Vigabatrin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00138	CcSEcCtD
Vigabatrin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00138	0.00138	CcSEcCtD
Vigabatrin—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00137	CcSEcCtD
Vigabatrin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00137	CcSEcCtD
Vigabatrin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00137	CcSEcCtD
Vigabatrin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00137	0.00137	CcSEcCtD
Vigabatrin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00137	CcSEcCtD
Vigabatrin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00136	CcSEcCtD
Vigabatrin—Infection—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00136	CcSEcCtD
Vigabatrin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00136	CcSEcCtD
Vigabatrin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00136	CcSEcCtD
Vigabatrin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00136	0.00136	CcSEcCtD
Vigabatrin—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Vigabatrin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00134	CcSEcCtD
Vigabatrin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00134	0.00134	CcSEcCtD
Vigabatrin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00133	CcSEcCtD
Vigabatrin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Vigabatrin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00131	CcSEcCtD
Vigabatrin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.0013	CcSEcCtD
Vigabatrin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.0013	CcSEcCtD
Vigabatrin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Vigabatrin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Vigabatrin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Vigabatrin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Vigabatrin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Vigabatrin—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Vigabatrin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00124	CcSEcCtD
Vigabatrin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00124	CcSEcCtD
Vigabatrin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00124	0.00124	CcSEcCtD
Vigabatrin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Vigabatrin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Vigabatrin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Vigabatrin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Vigabatrin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Vigabatrin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Vigabatrin—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Vigabatrin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Vigabatrin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Vigabatrin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Vigabatrin—Pain—Formoterol—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Vigabatrin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Vigabatrin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Vigabatrin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Vigabatrin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Vigabatrin—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.00119	0.00119	CcSEcCtD
Vigabatrin—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00119	0.00119	CcSEcCtD
Vigabatrin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00119	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00118	CcSEcCtD
Vigabatrin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00118	CcSEcCtD
Vigabatrin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00118	CcSEcCtD
Vigabatrin—Pain—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00117	CcSEcCtD
Vigabatrin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.00117	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00117	CcSEcCtD
Vigabatrin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Vigabatrin—Purpura—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Vigabatrin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Vigabatrin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Vigabatrin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Vigabatrin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Vigabatrin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Vigabatrin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Vigabatrin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Vigabatrin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Vigabatrin—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Vigabatrin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Vigabatrin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Vigabatrin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Vigabatrin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Vigabatrin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Vigabatrin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Vigabatrin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Vigabatrin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Vigabatrin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Vigabatrin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Vigabatrin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Vigabatrin—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.0011	0.0011	CcSEcCtD
Vigabatrin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.0011	CcSEcCtD
Vigabatrin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Vigabatrin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Vigabatrin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Vigabatrin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Vigabatrin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Vigabatrin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Vigabatrin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Vigabatrin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Vigabatrin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Vigabatrin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Vigabatrin—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Vigabatrin—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00106	CcSEcCtD
Vigabatrin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Vigabatrin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00104	CcSEcCtD
Vigabatrin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00104	CcSEcCtD
Vigabatrin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Vigabatrin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Vigabatrin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Vigabatrin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Vigabatrin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00101	CcSEcCtD
Vigabatrin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.001	0.001	CcSEcCtD
Vigabatrin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.001	0.001	CcSEcCtD
Vigabatrin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00099	0.00099	CcSEcCtD
Vigabatrin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00099	0.00099	CcSEcCtD
Vigabatrin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000984	0.000984	CcSEcCtD
Vigabatrin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000975	0.000975	CcSEcCtD
Vigabatrin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000974	0.000974	CcSEcCtD
Vigabatrin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00097	0.00097	CcSEcCtD
Vigabatrin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000958	0.000958	CcSEcCtD
Vigabatrin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000958	0.000958	CcSEcCtD
Vigabatrin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000948	0.000948	CcSEcCtD
Vigabatrin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000938	0.000938	CcSEcCtD
Vigabatrin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000935	0.000935	CcSEcCtD
Vigabatrin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000926	0.000926	CcSEcCtD
Vigabatrin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000926	0.000926	CcSEcCtD
Vigabatrin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000907	0.000907	CcSEcCtD
Vigabatrin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000904	0.000904	CcSEcCtD
Vigabatrin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000892	0.000892	CcSEcCtD
Vigabatrin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00089	0.00089	CcSEcCtD
Vigabatrin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00089	0.00089	CcSEcCtD
Vigabatrin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000883	0.000883	CcSEcCtD
Vigabatrin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000883	0.000883	CcSEcCtD
Vigabatrin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000882	0.000882	CcSEcCtD
Vigabatrin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000882	0.000882	CcSEcCtD
Vigabatrin—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000882	0.000882	CcSEcCtD
Vigabatrin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000877	0.000877	CcSEcCtD
Vigabatrin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000877	0.000877	CcSEcCtD
Vigabatrin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000875	0.000875	CcSEcCtD
Vigabatrin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000874	0.000874	CcSEcCtD
Vigabatrin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000872	0.000872	CcSEcCtD
Vigabatrin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000864	0.000864	CcSEcCtD
Vigabatrin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000864	0.000864	CcSEcCtD
Vigabatrin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000862	0.000862	CcSEcCtD
Vigabatrin—Depression—Prednisone—chronic obstructive pulmonary disease	0.000861	0.000861	CcSEcCtD
Vigabatrin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000859	0.000859	CcSEcCtD
Vigabatrin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000849	0.000849	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000847	0.000847	CcSEcCtD
Vigabatrin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00084	0.00084	CcSEcCtD
Vigabatrin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000838	0.000838	CcSEcCtD
Vigabatrin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000835	0.000835	CcSEcCtD
Vigabatrin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000833	0.000833	CcSEcCtD
Vigabatrin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000833	0.000833	CcSEcCtD
Vigabatrin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000831	0.000831	CcSEcCtD
Vigabatrin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000831	0.000831	CcSEcCtD
Vigabatrin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000828	0.000828	CcSEcCtD
Vigabatrin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000814	0.000814	CcSEcCtD
Vigabatrin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000805	0.000805	CcSEcCtD
Vigabatrin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000785	0.000785	CcSEcCtD
Vigabatrin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000781	0.000781	CcSEcCtD
Vigabatrin—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000771	0.000771	CcSEcCtD
Vigabatrin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000762	0.000762	CcSEcCtD
Vigabatrin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000758	0.000758	CcSEcCtD
Vigabatrin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000725	0.000725	CcSEcCtD
Vigabatrin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000686	0.000686	CcSEcCtD
Vigabatrin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000681	0.000681	CcSEcCtD
Vigabatrin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000679	0.000679	CcSEcCtD
Vigabatrin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000675	0.000675	CcSEcCtD
Vigabatrin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000648	0.000648	CcSEcCtD
Vigabatrin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000636	0.000636	CcSEcCtD
Vigabatrin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000626	0.000626	CcSEcCtD
Vigabatrin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000625	0.000625	CcSEcCtD
Vigabatrin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000624	0.000624	CcSEcCtD
Vigabatrin—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00062	0.00062	CcSEcCtD
Vigabatrin—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000617	0.000617	CcSEcCtD
Vigabatrin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000609	0.000609	CcSEcCtD
Vigabatrin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000606	0.000606	CcSEcCtD
Vigabatrin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000602	0.000602	CcSEcCtD
Vigabatrin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000585	0.000585	CcSEcCtD
Vigabatrin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000575	0.000575	CcSEcCtD
Vigabatrin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000575	0.000575	CcSEcCtD
Vigabatrin—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000573	0.000573	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000571	0.000571	CcSEcCtD
Vigabatrin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000568	0.000568	CcSEcCtD
Vigabatrin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000559	0.000559	CcSEcCtD
Vigabatrin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000551	0.000551	CcSEcCtD
Vigabatrin—Infection—Prednisone—chronic obstructive pulmonary disease	0.000547	0.000547	CcSEcCtD
Vigabatrin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00054	0.00054	CcSEcCtD
Vigabatrin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000535	0.000535	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000502	0.000502	CcSEcCtD
Vigabatrin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000501	0.000501	CcSEcCtD
Vigabatrin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000498	0.000498	CcSEcCtD
Vigabatrin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000495	0.000495	CcSEcCtD
Vigabatrin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000485	0.000485	CcSEcCtD
Vigabatrin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000479	0.000479	CcSEcCtD
Vigabatrin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000478	0.000478	CcSEcCtD
Vigabatrin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000478	0.000478	CcSEcCtD
Vigabatrin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000475	0.000475	CcSEcCtD
Vigabatrin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000475	0.000475	CcSEcCtD
Vigabatrin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000471	0.000471	CcSEcCtD
Vigabatrin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000454	0.000454	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00045	0.00045	CcSEcCtD
Vigabatrin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00045	0.00045	CcSEcCtD
Vigabatrin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000438	0.000438	CcSEcCtD
Vigabatrin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000435	0.000435	CcSEcCtD
Vigabatrin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000435	0.000435	CcSEcCtD
Vigabatrin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000406	0.000406	CcSEcCtD
Vigabatrin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000395	0.000395	CcSEcCtD
Vigabatrin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00039	0.00039	CcSEcCtD
Vigabatrin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000377	0.000377	CcSEcCtD
Vigabatrin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000364	0.000364	CcSEcCtD
Vigabatrin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00035	0.00035	CcSEcCtD
Vigabatrin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000347	0.000347	CcSEcCtD
Vigabatrin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000347	0.000347	CcSEcCtD
Vigabatrin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000345	0.000345	CcSEcCtD
Vigabatrin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000327	0.000327	CcSEcCtD
